Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

  2021 2020 2019 2018 2017 2016

Year wise published articles

50 27 55 66 38 13

Year wise citations received

494 462 352 277 260 226
Journal total citations count 3847
Journal impact factor 12.24
Journal 5 years impact factor 8.50
Journal cite score 10.62
Journal h-index 29
Journal h-index since 2018 21
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Jankovic J, Poewe W (2012) Therapies in Parkinson's disease. Current opinion in neurology 25: 433-447.

    View at Publisher | View at Google Scholar
  • Romano-Bertrand S, Dupont C, Marchandin H, Jumas-Bilak E and Licznar-Fajardo P, Reducing pathobiomes could slow arms race between man and microbes.

    View at Publisher | View at Google Scholar
  • KUZNETSOV V, LEE H, MAURER-STROH S, MOLNÁR MJ, PONGOR S, et al. 2014. 8.1 WHEN WILL GENOME SEQUENCES, EXPRESSION PROFILES, AND COMPUTER VISION FOR BIOIMAGE INTERPRETATION BE ROUTINELY USED IN CLINICAL MEDICINE?. Omics in Clinical Practice: Genomics, Pharmacogenomics, Proteomics, and Transcriptomics in Clinical Research, p.203.

    View at Publisher | View at Google Scholar
  • Syed SA, Whelan FJ, Waddell B, Rabin HR, Parkins MD, et al. 2016. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis. Annals of the American Thoracic Society, 13(12), pp.2132-2142.

    View at Publisher | View at Google Scholar
  • Zemanick ET and Harris JK, 2013. The Human Airway Microbiome. The Human Microbiota: How Microbial Communities Affect Health and Disease, pp.119-134.

    View at Publisher | View at Google Scholar
  • Liu KE, Love AC and Travisano M, 2016. 5 How Cancer Spreads. Philosophy of Molecular Medicine: Foundational Issues in Research and Practice.

    View at Publisher | View at Google Scholar
  • Waite RD, Qureshi MR and Whiley RA, 2017. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus. PloS one, 12(3), p.e0173741.

    View at Publisher | View at Google Scholar
  • Waite RD, Qureshi MR and Whiley RA, 2017. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus. PloS one, 12(3), p.e0173741.

    View at Publisher | View at Google Scholar
  • Lacroix AMG, 2014. Investigation of Competence Heterogeneity in Streptococcus Milleri Group Clinical Isolates (Doctoral dissertation).

    View at Publisher | View at Google Scholar
  • Schlam D, 2016. Regulation of Phagocyte Immunity by Lipid Signals (Doctoral dissertation, University of Toronto (Canada)).

    View at Publisher | View at Google Scholar
  • Fang J, 2014. Study of Specialized Metabolites Produced by Pseudomonas aeruginosa Using Mass Spectrometry.

    View at Publisher | View at Google Scholar
  • Denman CC, 2013. From Osmolytes to Diabetes: the Impact of Sugars and Sugar Alcohols on the Cystic Fibrosis Pathogen, Burkholderia multivorans.

    View at Publisher | View at Google Scholar
  • Barott KL, 2012. Competition between coral and algal holobionts.

    View at Publisher | View at Google Scholar
  • Zhao Y, 2014. Pseudomonas aeruginosa type III secretion system: regulation and potential role in interspecies interaction (Doctoral dissertation, University of Manitoba).

    View at Publisher | View at Google Scholar
  • Kirkup Jr BC, 2014. Counterinsurgency Doctrine Applied to Infectious Disease (Doctoral dissertation, School of Medicine, Uniformed Services University of the Health Sciences).

    View at Publisher | View at Google Scholar
  • Nolan LM, 2014. The role of small molecule signalling in biofilm migration of Pseudomonas aeruginosa (Doctoral dissertation).

    View at Publisher | View at Google Scholar
  • Lopes SP, Carvalho DT, Pereira MO and Azevedo NF, 2017. Discriminating typical and atypical cystic fibrosis‐related bacteria by multiplex PNA‐FISH. Biotechnology and Bioengineering, 114(2), pp.355-367.

    View at Publisher | View at Google Scholar
  • Bhagirath AY, Li Y, Somayajula D, Dadashi M, Badr S, et al. 2016. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulmonary Medicine, 16(1), p.174.

    View at Publisher | View at Google Scholar
  • Singh P, 2011. Structural and Functional Characterization of Bacterial Secretion Systems Using Mass Spectrometry. University of Washington.

    View at Publisher | View at Google Scholar
  • Halverson TWR, 2013. The role of extracellular DNA in neutrophil extracellular traps (Doctoral dissertation, University of Calgary).

    View at Publisher | View at Google Scholar
  • Sato Y, 2012. Ecology and microbiology of black band disease: new insights into the etiology of an old coral disease (Doctoral dissertation, James Cook University).

    View at Publisher | View at Google Scholar
  • Mougous J, University Of Washington, 2010. Toxin-Immunity System. U.S. Patent Application 13/516,158.

    View at Publisher | View at Google Scholar
  • Hoppe JE, Harris JK and Zemanick ET, 2016. Assessing the Airway Microbiota in Cystic Fibrosis. Clinical Microbiology Newsletter, 38(22), pp.179-184.

    View at Publisher | View at Google Scholar
  • Jensen D, 2015. Next-gen Transcriptomics Reveals Variable Gene Expression in Stenotrophomonas Maltophilia K279A when Grown in Co-culture with Pseudomonas Aeruginosa 2192 (Doctoral dissertation, University of Louisville).

    View at Publisher | View at Google Scholar
  • Cline JM, Scott P, Kainulainen K and Weniger C, 2013. UvA-DARE (Digital Academic Repository). PHYSICAL REVIEW D Phys Rev D, 88, p.055025.

    View at Publisher | View at Google Scholar
  • Peled O, Kalamaro V, Kerem E, Shoseyov D, Blau H, et al. 2014. Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel. Journal of Cystic Fibrosis, 13(5), pp.550-556.

    View at Publisher | View at Google Scholar
  • Chen T, Wang R, Lu T, Zhang Y and Wang W, 2009.Inhibitory effect of cationic polyethyleneimine polymer on penicillin antibiotics. Chinese Journal of Pharmaceutical Sciences, (9), pp. 674-678.

    View at Publisher | View at Google Scholar
  • Linh NDN, Development of high-throughput sequencing analysis of fungal and respiratory microbiota in patients with cystic fibrosis.

    View at Publisher | View at Google Scholar
  • Michon AL and Marchandin H, 2015. Physiopathological diversity of the respiratory microbiota. Revue Francophone des Laboratoires, 2015 (469), pp.37-49.

    View at Publisher | View at Google Scholar
  • Cao W, Zhang G and Wang C, 2011. Advances in myeloid cell trigger receptor-1. Chinese Journal of Basic and Clinical Medicine, 18 (10), pp.1118-1121.

    View at Publisher | View at Google Scholar
  • Elborn JS, 2011. Treating cystic fibrosis infection, inflammation and ion channels. Therapy, 8(6), pp.583-585.

    View at Publisher | View at Google Scholar
  • Fasinu P, Pillay V, Ndesendo VM, du Toit LC, Choonara YE (2011) Diverse approaches for the enhancement of oral drug bioavailability. Biopharmaceutics & drug disposition 32: 185-209.

    View at Publisher | View at Google Scholar
  • Stacy M (2009) Medical treatment of Parkinson disease. Neurologic clinics 27:605-631.

    View at Publisher | View at Google Scholar
  • Hribar G, Žnidaršič A, Bele M, Maver U, Caserman S, et al. 2011. Zinc-phosphate nanoparticles with reversibly attached TNF-α analogs: an interesting concept for potential use in active immunotherapy. Journal of Nanoparticle Research, 13(7), pp.3019-3032.

    View at Publisher | View at Google Scholar
  • Seeberger LC, Hauser RA (2007) Optimizing bioavailability in the treatment of Parkinson's disease. Neuropharmacology 53:791-800.

    View at Publisher | View at Google Scholar
  • Elborn JS, 2011. Treating cystic fibrosis infection, inflammation and ion channels. Therapy, 8(6), pp.583-585.

    View at Publisher | View at Google Scholar
  • Elborn JS, 2011. Treating cystic fibrosis infection, inflammation and ion channels. Therapy, 8(6), pp.583-585.

    View at Publisher | View at Google Scholar
  • Chowdary KP, Shankar KR, Suchitra B (2014) Recent Research on Orodispersible Tablets-A Review. Int Res J Pharm App Sci 4: 64-73

    View at Publisher | View at Google Scholar
  • Li L and Somerset S, 2014. The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies. Clinical Nutrition, 33(4), pp.571-580.

    View at Publisher | View at Google Scholar
  • Van Arnum P (2007) Advancing ODT technology.

    View at Publisher | View at Google Scholar
  • De Boeck K, 2013. The future: from the bench to the patient. future, pp.94-103.

    View at Publisher | View at Google Scholar
  • Elborn JS, 2011. Treating cystic fibrosis infection, inflammation and ion channels. Therapy, 8(6), pp.583-585.

    View at Publisher | View at Google Scholar
  • Venkatesh G (2009) Granulation approaches for orally disintegrating formulations. InHandbook of Pharmaceutical Granulation Technology, Third Edition 401-434.

    View at Publisher | View at Google Scholar
  • Ananthan A, Balasubramanian H, Rao S and Patole S, 2016. Probiotic supplementation in children with cystic fibrosis—a systematic review. European journal of pediatrics, 175(10), pp.1255-1266.

    View at Publisher | View at Google Scholar
  • Chowdary KP, Aishwarya KV (2013) PREPARATION AND EVALUATION OF FAST DISSOLVING TABLETS OF PARACETAMOL EMPLOYING SUPERDISINTEGRANTS. Journal of global trends in Pharmaceutical Sciences 4: 1329-1334.

    View at Publisher | View at Google Scholar
  • Eickmeier O, Fußbroich D, van Dullemen S, Hill C, Smaczny C, et al. 2015. Inflammation and nutrition in mucoviscidosis. The pneumologist, 12 (2), pp.148-154.

    View at Publisher | View at Google Scholar
  • Chowdary KP, Aishwarya KV (2014) Preparation and evaluation of fast dissolving tablets of selected drugs employing superdisintegrants. JGTPS 5: 1392-1398.

    View at Publisher | View at Google Scholar
  • McLaughlin D, Banbury S (2007) ODTs help make the medicine go down. manufacturing chemist.

    View at Publisher | View at Google Scholar
  • Szakonyi G (2014) Investigation, development and evaluation of orally disintegrating tablets (Doctoral dissertation).

    View at Publisher | View at Google Scholar
  • Chowdary KP, Aishwarya KV (2013) Available online at www. JGTPS. com. Journal of Global Trends in Pharmaceutical Sciences 4: 940-954.

    View at Publisher | View at Google Scholar

Relevant Topics

Awards Nomination

Select your language of interest to view the total content in your interested language

Journal Metrics:

Impact Factor: 12.24
Journal Citescore: 10.62
h-index: 29
PubMed NLM ID:  101579384
Journal Acceptance Rate: 40%
Article processing time : 30-45 Days

Google Scholar citation report
Citations : 3847

Clinical Practice received 3847 citations as per Google Scholar report


Clinical Practice peer review process verified at publons

Indexed In

flyer
flyer